Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L35a pseudogene 12 (RPL35AP12) is a processed pseudogene related to the ribosomal protein L35a gene (RPL35A) found in the human genome[4]. Pseudogenes like RPL35AP12 are genomic DNA sequences similar to normal genes but are typically non-functional and do not code for active proteins. RPL35AP12 does not have a known role in cellular biology, and there is no evidence supporting its involvement as a therapeutic target or disease marker. Its presence reflects the genomic history of gene duplication and retrotransposition rather than functional biology. The functional parent gene, RPL35A, is a structural component of the ribosome and mutations in RPL35A are implicated in Diamond-Blackfan anemia, but such disease associations are not relevant to RPL35AP12 as a pseudogene[2][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L35a pseudogene 12 (RPL35AP12).